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Abstract. In malaria-endemic regions, many medical facilities have limited capacity to diagnose non-malarial etiologies
of acute febrile illness (AFI). As a result, the etiology of AFI is seldom determined, although AFI remains a major cause of
morbidity in developing countries. An outbreak of AFI was reported in the Afar region of Ethiopia in August of 2011.
Retrospectively, 12,816 suspected AFI cases were identified by review of medical records. Symptoms were mild and self-
limiting within 3 days after the date of onset; no fatalities were identified. All initial test results of AFI patient specimens
were negative for selected pathogens using standard microbiological and molecular techniques. High-throughput
sequencing of nucleic acid extracts of serum specimens from 29 AFI cases identified 17 (59%) of 29 samples as positive
for Sandfly Fever Sicilian Virus (SFSV). These results were further confirmed by specific reverse transcription polymerase
chain reaction. This is the first study implicating SFSV as an etiological agent for AFI in Ethiopia.
INTRODUCTION
Acute febrile illnesses (AFI) caused by a variety of pathogens
pose a major public health challenge, in part because clinical
examination cannot distinguish specific etiologies. Furthermore,
practical and affordable diagnostic tests for the diagnosis of non-
malarial etiologies of AFI are often not available in developing
countries.1–3 Consequently, the incidence and relative impor-
tance of the etiologic agents responsible for AFI remain
unknown in many parts of the world.2 This leads to potential
misdiagnosis, inappropriate patient management, and an inability
to effectively control or prevent additional cases. Sandfly fever,
caused by infection with the Sandfly Fever Sicilian Virus (SFSV),
is common in the Mediterranean region.4 SFSV is an arthropod-
borne virus that was first identified in Sicily, Italy in 1943 during
World War II as the etiology of sandfly fever that was a cause of
AFI in Allied armed forces.4 The virus is spread during the
summer season, which is the active period for Phlebotomus
papatasi,5 the main vector of SFSV. Other sandflies, such as
P. ariasi and sandflies of Larroussius group, also transmit SFSV.
Sandfly fever is a self-limited mild illness including fever, head-
ache, and muscle and joint pain; patients usually recover fully
within a few days.5 Serologic evidence of sandfly fever indicated
positive titers of SFSV from samples collected in Bangladesh,
Djibouti, Ethiopia, Iraq, Morocco, Saudi Arabia, Somalia,
Sudan, Tunisia, former republics of the Soviet Union, and
Yugoslavia.6 This investigation identified SFSV as the etiologic
agent in an AFI outbreak that was initially assumed to be caused
by malaria and later thought to be caused by dengue. To our
knowledge, this is the first report of sandfly fever in Ethiopia.
METHODS ANDMATERIALS
Samples were collected as a public health response under
the direction of the Ethiopian Health and Nutrition Research
Institute. As a public health response, this investigation
was not categorized as research, and informed consent was
not required.
In August of 2011, an outbreak of AFI was reported in
Asayta District, Afar Regional State, Ethiopia. The outbreak
later spread to two neighboring districts of Dubti and Afambo
(Figure 1). The illness was characterized by acute onset of fever,
chills, headache, and myalgia.
The regional health bureau (RHB) in the affected districts
sought assistance from the Ethiopian Health and Nutrition
Research Institute (EHNRI) when blood samples from
patients with AFI tested negative for malaria. The national
outbreak investigation team from the EHNRI initiated an
investigation by examining medical records from five local
health facilities. Using medical records, a suspect AFI case
was defined as acute onset of fever, chills, headache, and
myalagia from August 7 to September 12, 2011.
The national outbreak investigation team collected blood
specimens from 29 acutely ill patients with AFI. These speci-
mens were tested for malaria using a rapid diagnostic test
(CareStart Malaria HRP2 [Pf] Test; Access Bio, Inc., Somerset,
NJ) or microscopy on blood smears. In addition, samples were
subcultured onto blood, chocolate, and MacConkey agar.
Sera, which had been stored at −80°C, from 29 acutely ill
patients were transported to the Centers for Disease Control
and Prevention (CDC) laboratories at the Kenya Medical
Research Institute (KEMRI) in Kenya for real-time polymer-
ase chain reaction (PCR) testing. Total nucleic acid extraction
was performed using the MagMAX Viral RNA Isolation Kit
(Life Technologies, Foster City, CA) as per the manufac-
turer’s instructions. Amplification was done using the
AgPath-ID One-Step RT-PCR Kit (Applied Biosystems,
Carlsbad, CA) in individual PCR assays for dengue, Rift
Valley fever (RVF), yellow fever (YF), filoviruses (Ebola zaire
virus, Ebola bundibugyo virus, Ebola sudan virus, and Marburg
virus), chikungunya, and Crimean-Congo Hemorrhagic Fever
(CCHF) viruses. Primers and probes for the filoviruses were
obtained from the CDC, Viral Special Pathogens Branch in
Atlanta, Georgia. Primers and probes for YF, dengue, and RVF
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have previously been described, whereas those of chikungunya
virus were obtained from the Division of Vector-Borne Diseases,
CDC, in Fort Collins, Colorado.7 Thermal cycling conditions
included reverse transcription at 45°C for 10 minutes, AmpliTaq
Polymerase activation at 95°C for 10 minutes, and then, 45 cycles
of denaturation at 95°C for 15 seconds and primer annealing/
extension at 55°C for 1 minute.
Total nucleic acids from 29 of the serum specimens
were transported to Washington University in St. Louis for
next-generation sequencing analysis. Nucleic acids were
randomly amplified by sequence-independent PCR using
barcoded primers, pooled, and sequenced in one run on the
Roche Titanium/FLX platform as described previously.8
Sequences were compared with publicly available sequence
databases using a customized bioinformatics platform as
previously described to identify microbial sequences present
in the sample.9 Contig assembly was performed with the
Newbler assembler.
For result confirmation, RNA was extracted from speci-
mens positive by next-generation sequencing and subjected
to a phlebovirus-specific consensus reverse transcription
PCR (RT-PCR) assay. Resultant amplicons were sequenced
using previously described methods at the CDC Division of
Vector-Borne Diseases in Fort Collins, Colorado.10 All
generated partial S-segment sequences were deemed identi-
cal in the amplified region. A phylogenetic analysis was con-
ducted on a representative partial S-segment sequence
(284 bp; GenBank accession no. KJ372529), which maps to
nucleotides 139–422 of the GenBank reference SFSV-Turkey
sequence (GenBank accession no. NC_015413.1) along with
diverse SFSV sequences that are available in GenBank.
Alignments were generated using the Clustal W function
of MEGA, version 4 software.11,12 A neighbor-joining tree
was generated and analyzed with 2,000 replicates for boot-
strap testing.13
RESULTS
In total, 12,816 suspect AFI cases were identified between
August 7 and September 12, 2011 through the medical records
review from five health centers in Afambo, Asayta, and Dubti
Districts of the Afar region (Figure 2); 9,107 (71%) cases were
male. For 29 patients from whom sera was collected, the age
distribution ranged from 2 to 55 years of age, with a mean age
of 25 years old. Patient symptoms were mild and self-limiting,
with patients recovering within 3–4 days after date of symp-
tom onset.
All 29 blood samples tested negative for malaria (Plasmo-
dium falciparum and P. vivax) by microscopy. In addition,
bacterial culture failed to identify any potential etiologies.
The 29 serum specimens tested negative for dengue, RVF,
YF, filoviruses, chikungunya, and CCHF viruses by real-time
Figure 1. Acute febrile illness outbreak affected districts of Afar region, Ethiopia, 2011.
Figure 2. Suspect AFI cases by date of onset, Afar, August 7
to September 11, 2011.
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PCR. Attempts to culture virus from selected samples on
Vero cells were unsuccessful.
After next-generation sequencing, computational analysis
detected one or more nucleic acid sequences with ³ 97%
nucleotide identity to SFSV in 17 (59%) of 29 specimens. In
addition, one specimen was positive for hepatitis B and SFSV;
two specimens were positive for hepatitis GBV-C sequences,
one of which was positive for SFSV.
To further analyze the SFSV-like sequence, data from one
sample, where more than 1,000 of approximately 30,000 total
reads derived from SFSV, were assembled. Contigs of
6,355 nucleotides (GenBank accession no. KM042102) and
4,349 nucleotides (GenBank accession no. KM042103) that
correspond to the nearly complete L and M segments of SFSV,
respectively, were generated. In addition, two shorter contigs of
790 and 767 nucleotides (GenBank accession nos. KM042104
and KM042105) were generated that aligned to different
regions of the S segment of SFSV (with a gap of approximately
100 nucleotides). The four contigs shared 97–99% nucleotide
identity to the reference SFSV-Turkey strain in GenBank
(accession nos. NC_015411.1, NC_015412.1, and NC_015413.1).
Of 17 specimens sent to the CDC in Ft. Collins, Colorado for
confirmatory testing, 7 (41%) specimens were SFSV-positive
by RT-PCR, and 2 (12%) specimens were indeterminate. All
seven positive samples yielded identical amplicons. The resul-
tant tree reveals a strongly supported association between the
SFSV sequences detected in Ethiopia and strains that were
isolated in recent years from Cyprus (2002) and Turkey
(2008), with Uukeniemi virus as the outgroup (Figure 3).
DISCUSSION
This is the first report of SFSV as the etiology of AFI in
Ethiopia. The symptoms, which were mild and self-limiting
within 3–4 days, are identical to those in previous reports
of SFSV infection, also known as 3-day fever.6,14
Human case reports and seroprevalence studies have
suggested that SFSV or an SFSV-like virus circulates in the
Mediterranean region.4 Recently, molecular evidence showed
the presence of two distinct phleboviruses closely related to
SFSV in Algeria and Tunisia.15,16 Nucleic acids detected in
this study within positive samples shared approximately 99%
nucleotide sequence identity with strains that were associated
with human illness in Cyprus and Turkey in 2008, implicating
a possible Eastern Mediterranean origin of the Ethiopian
strain of SFSV.
This large outbreak of AFI was initially identified through an
extensive medical records review, and although only 29 speci-
mens were ultimately collected, 17 specimens contained
nucleic acid sequences that were ³ 97% identical to SFSV
using a next-generation sequencing-based assay. These results
were independently corroborated by RT-PCR in 7 of 17 speci-
mens in a different laboratory (CDC, Fort Collins, CO).
Sequences obtained in these seven specimens were identical to
those obtained in the Washington University laboratory.
There were a number of limitations to this study. An
attempt to isolate a pathogen on Vero cells was unsuccessful
(data not shown). Because of resource limitations, no vector
assessment was conducted. Case identification was a challenge
because of the pastoral nature of the affected community.
Limited specimens were collected relative to the great size of
the affected area, in part because cases were on the wane by
the time that the investigative team arrived.
Although the epidemiologic investigation provided limited
information on risk factors for infection or clues to potential
etiologic agents, detection of SFSV in these specimens by
high-throughput sequencing underscores the power of unbiased
metagenomic strategies for pathogen detection. It is unclear at
this point whether detection of sandfly fever reflects a recent
expansion in the geographic range of the virus beyond the
Mediterranean region or alternately, previously unrecognized
endemicity uncovered by the increased diagnostic breadth of
the unbiased next-generation sequencing assay. Broader stud-
ies are needed to determine the prevalence of sandfly fever in
this geographic area. Furthermore, disease surveillance
should be implemented in endemic regions to monitor the
trends and quickly identify an outbreak. Surveillance would
also provide data to the national level on disease burden and
etiological agents of focus in resource-limited settings.
This outbreak highlights the diagnostic challenges in iden-
tifying etiologic agents responsible for AFI outbreaks in
developing countries. AFI cases usually go uncharacterized
in resource-limited settings and are mainly treated as malaria
or typhoid. In our study, the outbreak etiological identifica-
tion was inefficient primarily because of the lack of advanced
molecular techniques, which necessitated international col-
laboration. Although etiological identification was successful
in this instance, this approach is not cost-effective considering
Figure 3. Phylogeny of the partial S segment of a geographic diversity of sandfly fever viruses. A neighbor-joining tree with bootstrap values
determined by 2000 replicates is shown. The scale bar represents the number of nucleotide substitutions per site.
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the burden of AFI outbreaks in sub-Saharan Africa. There is
a great need to develop laboratory capacity for both tradi-
tional microbiology and molecular techniques to improve
identification of agents responsible for causing outbreaks of
AFI in developing countries.
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